Comparison of efficacy and safety of insulin detemir in combination with insulin aspart and biphasic insulin aspart 30 [insulin aspart/insulin protamine aspart] in type 2 diabetes mellitus.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Insulin aspart; Insulin aspart/insulin protamine aspart; Insulin detemir
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms PreFER
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 01 Jul 2009 Actual end date (1 Mar 2005) added as reported by ClinicalTrials.gov.
- 01 Jan 2009 Results have been published in Diabetes, Obesity and Metabolism.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History